Join the Depression group to help and get support from people like you.
Depression News (Page 23)
Related terms: Major Depression, Unipolar Depression
Some Environmental Toxicants Linked to Depressive Symptoms
TUESDAY, July 9, 2024 – Certain categories of environmental toxicants are associated with depressive symptoms, according to a study published online July 3 in JAMA Network Open. Jianhui Guo, M.D.,...
After Cardiac Arrest, Women More Likely to Suffer Anxiety, Depression Than Men
TUESDAY, July 9, 2024 – Women who survive cardiac arrest are more likely to suffer anxiety or depression than male survivors, a new study warns. Data regarding the five-year health consequences of a...
Postpartum Urinary Incontinence Takes Physical, Mental Toll
MONDAY, July 8, 2024 – Urinary incontinence is a common aftereffect of delivering a baby, but it can have a devastating effect on new moms, a new study warns. These bladder leaks are significantly...
Study Looks at Depression, Stress in Both Parents After Detection of Fetal Anomalies
MONDAY, July 8, 2024 – Prospective parents experience heightened levels of depression and traumatic stress after the detection of fetal anomalies leading to termination of pregnancy, according to a...
FDA Approves Auvelity (dextromethorphan and bupropion) for the Treatment of Major Depressive Disorder in Adults
Auvelity is the first and only rapid-acting oral treatment approved with labeling of statistically significant improvement in depressive symptoms compared to placebo starting at one week11-4...
Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for Caplyta (lumateperone) for Specific Patient Populations
Caplyta label now includes dosage recommendations for specific patient populations; those with moderate or severe hepatic impairment and patients who are concomitantly taking moderate or strong...
FDA Approves Spravato (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior
TITUSVILLE, N.J. – (August 3, 2020) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug ...
FDA Approves Expanded Use of Vraylar (cariprazine) in the Treatment of Bipolar Depression
DUBLIN and BUDAPEST, Hungary, May 28, 2019 /PRNewswire/ – Allergan plc (NYSE: AGN) and Gedeon Richter Plc. today announced that the U.S. Food and Drug Administration (FDA) has approved a...
FDA Approves Zulresso (brexanolone) for the Treatment of Postpartum Depression
March 19, 2019 -- The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This ...
FDA Approves Spravato (esketamine) Nasal Spray for Treatment-Resistant Depression
March 5, 2019 – The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have...
FDA Approves Latuda (lurasidone HCl) for Bipolar Depression in Pediatric Patients (10 to 17 Years of Age)
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- March 6, 2018 – Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug...
FDA Approves Abilify MyCite (aripiprazole) Pill with Sensor to Digitally Track if Patients Have Ingested Their Medication
November 13, 2017 – The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an...
Brintellix (vortioxetine) Renamed Trintellix (vortioxetine) in U.S. to Avoid Name Confusion
Deerfield, Ill., and Osaka, Japan (May 2, 2016) – Takeda Pharmaceuticals U.S.A., Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) (collectively “Takeda”), and Lundb...
FDA Medwatch Alert: Brintellix (vortioxetine): Drug Safety Communication - Brand Name Change to Trintellix, to Avoid Confusion With Antiplatelet Drug Brilinta (ticagrelor)
ISSUE: FDA has approved a brand name change for the antidepressant Brintellix (vortioxetine) to decrease the risk of prescribing and dispensing errors resulting from name confusion with the ...
FDA Approves Rexulti (brexpiprazole) for Schizophrenia and Adjunctive Treatment for Major Depressive Disorder
Tokyo, Japan and Valby, Denmark – July 11, 2015 –Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced today that the U.S. Food and Drug Administration (FDA) approved Rex...
Further information
Related condition support groups
Major Depressive Disorder, Dysthymia, Sexual Dysfunction, SSRI Induced, Seasonal Affective Disorder, Postpartum Depression
Related drug support groups
Lexapro, tramadol, Zoloft, sertraline, Wellbutrin, Cymbalta, trazodone, Prozac, Effexor, view more... escitalopram, citalopram, bupropion, mirtazapine, Abilify, amitriptyline, venlafaxine, fluoxetine, Celexa, alprazolam, Paxil, Effexor XR, Pristiq, lithium, Wellbutrin XL, Viibryd, duloxetine, lamotrigine, quetiapine, Remeron, nortriptyline, paroxetine, Wellbutrin SR, olanzapine, methylphenidate, risperidone, Zyprexa, modafinil, aripiprazole, Elavil, doxepin, Seroquel XR, Rexulti, clomipramine, ketamine, valerian, fluvoxamine, niacin, desvenlafaxine